Literature DB >> 7513822

X-ray-induced transcriptional activation of c-myc and XRCC1 genes in ataxia telangiectasia cells.

B Shung1, J Miyakoshi, H Takebe.   

Abstract

The transcriptional level of c-myc, c-jun and XRCC1 genes after X-irradiation was compared in human cells originating from subjects presumably with different DNA repair abilities. The mRNA amount of the beta-actin gene was used as an internal standard of transcription. The relative mRNA level of c-myc and XRCC1 genes was significantly increased 15 min after X-irradiation with doses of 2-8 Gy in ataxia telangiectasia (AT) cells (AT5BIVA and TAT2SF), in contrast to little change in xeroderma pigmentosum (XP2OS(SV) and XP2YO(SV)) and normal cells (WI38VA13 and GM0637). The increased mRNA level of the XRCC1 gene in AT5BIVA and of the c-myc and XRCC1 genes in TAT2SF cells was maintained for up to 8 h after X-irradiation with 2 Gy. For the c-jun mRNA level after X-irradiation with 2-8 Gy, no significant change was observed in all cell lines tested. These results indicate that AT cells show a high transcriptional response of certain genes in response to X-irradiation, and suggest that the transcriptional activation of c-myc and XRCC1 genes after X-irradiation may be related to the hyper-radiosensitivity of AT cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513822     DOI: 10.1016/0027-5107(94)90276-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

Review 1.  Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells.

Authors:  H D Lohrer
Journal:  Experientia       Date:  1996-04-15

2.  E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.

Authors:  Dexi Chen; Zhiyong Yu; Zhiyi Zhu; Charles D Lopez
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

3.  Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene.

Authors:  J Miyakoshi; K Kitagawa; N Yamagishi; S Ohtsu; R S Day; H Takebe
Journal:  Jpn J Cancer Res       Date:  1997-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.